Case Reports
doi: 10.1016/0304-3959(91)90225-M.
Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine
Affiliations
- PMID: 1784504
- DOI: 10.1016/0304-3959(91)90225-M
Item in Clipboard
Case Reports
Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine
Pain.
1991 Dec.
Abstract
We report the case of a patient who developed myoclonus and hyperalgesia following administration of high-dose subarachnoid morphine. This complication occurred with 40-80 mg/day continuous infusion. The pathophysiology of these side effects is discussed.
Similar articles
-
Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine.Pain. 1993 Oct;55(1):93-97. doi: 10.1016/0304-3959(93)90188-U. Pain. 1993. PMID: 8278214
-
Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories.Acta Anaesthesiol Scand. 1998 Oct;42(9):1070-5. doi: 10.1111/j.1399-6576.1998.tb05378.x. Acta Anaesthesiol Scand. 1998. PMID: 9809090
-
Intrathecal morphine combined with ropivacaine induces spinal myoclonus in cancer patients with an implanted intrathecal drug delivery system: Three case reports.Medicine (Baltimore). 2019 May;98(18):e15330. doi: 10.1097/MD.0000000000015330. Medicine (Baltimore). 2019. PMID: 31045772 Free PMC article.
-
[Morphine-induced hyperalgesia, allodynia and myoclonus--new side-effects of morphine?].Ugeskr Laeger. 1995 Jun 5;157(23):3307-10. Ugeskr Laeger. 1995. PMID: 7543228 Review. Danish.
-
Myoclonus and urinary retention following subarachnoid morphine injection in a dog.Vet Anaesth Analg. 2003 Oct;30(4):257-64. doi: 10.1046/j.1467-2995.2003.00076.x. Vet Anaesth Analg. 2003. PMID: 12925183 Review.
Cited by
-
Differential tolerance to morphine antinociception in assays of pain-stimulated vs. pain-depressed behavior in rats.Eur J Pharmacol. 2015 Feb 5;748:76-82. doi: 10.1016/j.ejphar.2014.12.011. Epub 2014 Dec 18. Eur J Pharmacol. 2015. PMID: 25530266 Free PMC article.
-
Drug-induced movement disorders.Drug Saf. 1997 Mar;16(3):180-204. doi: 10.2165/00002018-199716030-00004. Drug Saf. 1997. PMID: 9098656 Review.
-
Role of NK-1 neurotransmission in opioid-induced hyperalgesia.Pain. 2005 Aug;116(3):276-288. doi: 10.1016/j.pain.2005.04.014. Pain. 2005. PMID: 15964684 Free PMC article.
-
Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers.J Neurosci. 2002 Aug 1;22(15):6747-55. doi: 10.1523/JNEUROSCI.22-15-06747.2002. J Neurosci. 2002. PMID: 12151554 Free PMC article.
-
Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations.CNS Drugs. 2015 Jun;29(6):465-86. doi: 10.1007/s40263-015-0255-x. CNS Drugs. 2015. PMID: 26142224 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
